(7aS,11aR)-2-(4-Methoxy-2-trifluoromethyl-phenyl)-5,6,7a,8,9,10,11,11a-octahydro-4H-pyrido[3',4':4,5]pyrrolo[3,2,1-ij]quinoline

ID: ALA2337102

PubChem CID: 59012632

Max Phase: Preclinical

Molecular Formula: C22H23F3N2O

Molecular Weight: 388.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2cc3c4c(c2)[C@@H]2CNCC[C@@H]2N4CCC3)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C22H23F3N2O/c1-28-15-4-5-16(19(11-15)22(23,24)25)14-9-13-3-2-8-27-20-6-7-26-12-18(20)17(10-14)21(13)27/h4-5,9-11,18,20,26H,2-3,6-8,12H2,1H3/t18-,20-/m0/s1

Standard InChI Key:  YLYUXVJVGYRALA-ICSRJNTNSA-N

Molfile:  

     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   18.3565   -3.7268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3554   -4.5464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0616   -3.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0599   -4.9525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0554   -5.7688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7624   -6.1848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4756   -5.7782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4817   -4.9557    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7702   -3.7233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7705   -4.5419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5487   -3.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0469   -4.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9435   -4.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3488   -3.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8506   -2.6092    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9471   -2.6622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1326   -2.7570    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   21.5070   -5.0228    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   17.6508   -3.3186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6519   -2.5003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9449   -2.0919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2363   -2.5008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2392   -3.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9467   -3.7268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3599   -2.0923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0673   -2.5014    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.3606   -1.2751    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.0637   -1.6757    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.5280   -2.0933    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5267   -1.2761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  4  1  0
  9  3  2  0
  3  1  1  0
 10  4  2  0
 10  8  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9 10  1  0
 11  9  1  0
 12  8  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 11 17  1  1
 12 18  1  1
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
  1 19  1  0
 20 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
 22 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2337102

    CID 59012632

Associated Targets(Human)

HTR2A Tclin Serotonin 2 receptors; 5-HT2a & 5-HT2c (792 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.43Molecular Weight (Monoisotopic): 388.1762AlogP: 4.59#Rotatable Bonds: 2
Polar Surface Area: 24.50Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.64CX LogP: 4.22CX LogD: 2.01
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.81Np Likeness Score: -0.24

References

1. Fevig JM, Feng J, Rossi KA, Miller KJ, Wu G, Hung CP, Ung T, Malmstrom SE, Zhang G, Keim WJ, Cullen MJ, Rohrbach KW, Qu Q, Gan J, Pelleymounter MA, Robl JA..  (2013)  Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.,  23  (1): [PMID:23177783] [10.1016/j.bmcl.2012.10.091]

Source